PROCEPT (PRCT) CFO Kevin Waters Sells 373 Shares

What Happened
Kevin Waters, EVP and Chief Financial Officer of PROCEPT BioRobotics (PRCT), reported a sale of 373 shares on September 9, 2026. The shares were disposed at $20.95 each for a total of $7,815. This sale was executed as part of a sell-to-cover process to satisfy tax withholding obligations following the vesting of restricted stock units (RSUs), so it is a routine tax-related sale rather than an investment decision signal.

Key Details

• Transaction date: 2026-09-09; Price: $20.95; Shares sold: 373; Total value: $7,815.
• Filing date: 2026-09-10 — filed promptly the next day (timely reporting).
• Shares owned after transaction: not disclosed in this Form 4.
• Footnote: Sale executed pursuant to the issuer’s sell-to-cover process to cover tax withholding for RSUs that vested on 2026-09-05 (Footnote F1).
• Transaction type: Sale (S) via sell-to-cover (tax withholding), not an outright market-driven sell for liquidity or trading.

Context
Sell-to-cover transactions are common when equity awards vest and are used solely to satisfy tax withholding; they generally do not indicate the insider’s view on the company’s prospects. For retail investors, purchases or directional sales initiated for reasons other than tax withholding tend to be more informative about insider sentiment.